Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Ferroptosis: past, present and future
2020 Standout
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
2018 StandoutNobel
Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity
2017 StandoutNobel
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
2010
The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis
2012
Atopic dermatitis
2015 Standout
Filaggrin Mutations Associated with Skin and Allergic Diseases
2011
Irritant-evoked activation and calcium modulation of the TRPA1 receptor
2020 StandoutNatureNobel
Thymic stromal lymphopoietin and allergic disease
2012
Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome
2010
Skin pH: From Basic SciencE to Basic Skin Care
2013 Standout
Ex-vivo Gene Therapy Restores LEKTI Activity and Corrects the Architecture of Netherton Syndrome-derived Skin Grafts
2010
Histone H3 Phosphorylation is Under the Opposite Tonic Control of Dopamine D2 and Adenosine A2A Receptors in Striatopallidal Neurons
2009
Protease inhibition as new therapeutic strategy for GI diseases
2016
Unleashing the therapeutic potential of human kallikrein-related serine proteases
2015
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
2014 Standout
Efficacy of a New Tonic Containing Urea, Lactate, Polidocanol, and <b><i>Glycyrrhiza inflata</i></b> Root Extract in the Treatment of a Dry, Itchy, and Subclinically Inflamed Scalp
2013 Standout
New concept of the pathogenesis of atopic dermatitis: Interplay among the barrier, allergy, and pruritus as a trinity
2013
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
2014 Standout
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
Programming dendritic cells to induce TH2 and tolerogenic responses
2010
Peeling off the genetics of atopic dermatitis–like congenital disorders
2014
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Revealing the human mucinome
2022 StandoutNobel
Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis
2014
New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation
2013
TSLP Expression: Cellular Sources, Triggers, and Regulatory Mechanisms
2012
Protease Activity Enhances Production of Thymic Stromal Lymphopoietin and Basophil Accumulation in Flaky Tail Mice
2013
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
2013
Control of adaptive immunity by the innate immune system
2015 Standout
Human Involucrin Promoter Mediates Repression-Resistant and Compartment-Specific LEKTI Expression
2011
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI
2016
Infant epidermal skin physiology: adaptation after birth
2011
Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors
2016
Immunology of Psoriasis
2014 Standout
Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis
2012
Atopic dermatitis: A practice parameter update 2012
2013
Toward the First Class of Suicide Inhibitors of Kallikreins Involved in Skin Diseases
2014
Insufficient interleukin‐12 signalling favours differentiation of human CD4+ and CD 8+ T cells into GATA ‐3+ and GATA ‐3+ T‐bet+ subsets in humanized mice
2014 StandoutNobel
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
Expanding the scope of N → S acyl transfer in native peptide sequences
2015 StandoutNobel
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
2019 Standout
Phase I Study Protocol for Ex Vivo Lentiviral Gene Therapy for the Inherited Skin Disease, Netherton Syndrome
2013
Treatment of Childhood Atopic Dermatitis and Economic Burden of Illness in Asia Pacific Countries
2015 Standout
Engineered protease inhibitors based on sunflower trypsin inhibitor-1 (SFTI-1) provide insights into the role of sequence and conformation in Laskowski mechanism inhibition
2015
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
New Paradigms in Type 2 Immunity
2012 Science
The role of skin barrier function in atopic dermatitis: an update
2012
Works of Aurélie Robin being referenced
Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
2009
Par2 Inactivation Inhibits Early Production of TSLP, but Not Cutaneous Inflammation, in Netherton Syndrome Adult Mouse Model
2010
The Alarmin Concept Applied to Human Renal Transplantation: Evidence for a Differential Implication of HMGB1 and IL-33
2014
Quantitative Changes in Gαolf Protein Levels, but not D1 Receptor, Alter Specifically Acute Responses to Psychostimulants
2006
Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing
2010
Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome
2014